Javitt Jonathan C

CIK 00013037823 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001303782

Recent Transactions

30 trades

Award
NRX Pharmaceuticals, Inc.$NRXP
Stock Option (right to buy)
2025-04-09+125,000→ 125,000 total
Purchase
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2024-12-17$1.17/sh+40,000→ 84,634 total
Purchase
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2023-08-23$0.33/sh+100,000→ 446,332 total
Purchase
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2023-08-22$0.32/sh+200,000→ 346,332 total
Gift
NRX Pharmaceuticals, Inc.$NRXP
Common Stock, par value $0.001 per share
2022-12-14−300,000→ 14,468,329 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
Common Stock, par value $0.001 per share
2022-12-07$1.00/sh−400,000→ 12,899,997 total
Purchase
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2022-06-01$0.58/sh+100,000→ 146,332 total
Purchase
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2022-06-01$58.00/sh+100,000→ 146,332 total
Award
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2021-05-24+1,422,000→ 1,422,000 total
Award
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2021-05-24+46,332→ 46,332 total
Award
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2021-05-24+13,348,997→ 13,348,997 total
Sale
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2009-10-22$0.32/sh−31,610→ 460,000 total
Sale
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2009-10-14$0.32/sh−60,000→ 491,610 total
Sale
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2009-10-06$0.34/sh−48,869→ 551,610 total
Sale
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2009-10-05$0.34/sh−87,509→ 600,479 total
Sale
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2009-10-02$0.34/sh−5,224→ 687,988 total
Sale
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2009-10-01$0.34/sh−2,800→ 693,212 total
Sale
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2009-09-30$0.32/sh−50,000→ 696,012 total
Sale
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2009-09-29$0.34/sh−213,988→ 746,012 total
Other
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2008-08-27+0→ 0 total
Purchase
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2008-08-03$275000.00/sh+960,000→ 960,000 total
Exercise/Conversion
NEXTGEN HEALTHCARE, INC.
Common stock
2005-06-17$49.39/sh+200→ 8,074 total
Exercise/Conversion
NEXTGEN HEALTHCARE, INC.
Common stock
2005-06-17$48.87/sh+549→ 8,074 total
Exercise/Conversion
NEXTGEN HEALTHCARE, INC.
Common stock
2005-06-17$49.40/sh+32→ 8,074 total
Exercise/Conversion
NEXTGEN HEALTHCARE, INC.
Common stock
2005-06-17$48.88/sh+700→ 8,074 total
Exercise/Conversion
NEXTGEN HEALTHCARE, INC.
Common stock
2005-06-17$48.93/sh+1,000→ 8,074 total
Exercise/Conversion
NEXTGEN HEALTHCARE, INC.
Common stock
2005-06-17$49.38/sh+267→ 8,074 total
Exercise/Conversion
NEXTGEN HEALTHCARE, INC.
Common stock
2005-06-17$49.37/sh+501→ 8,074 total
Exercise/Conversion
NEXTGEN HEALTHCARE, INC.
Common stock
2005-06-17$49.05/sh+751→ 8,074 total
Award
NEXTGEN HEALTHCARE, INC.
Stock option (right to buy)
2005-02-11+3,500→ 3,500 total

Companies

Recent Filings

Address

C/O BRAINSTORM CELL THERAPEUTICS INC. 110 EAST 59TH STREET

NEW YORK, NY, 10022

View on SEC.gov